ARS Pharmaceuticals Cash Flow Statement (2021-2025) | SPRY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Operating Activities
Net Income					-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.02B	-0.02B	0.05B	-0.04B	-0.05B	-0.05B
Depreciation and Depletion	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Share-based Compensation	0.00B	0.00B	0.01B	-0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B
Gains from Investment Securities		0.01B		0.00B	-0.00B	0.00B	-0.00B		0.02B	0.00B	0.00B	0.00B	0.01B		0.02B	0.01B	0.02B	0.00B	0.02B
Non-cash Items		0.12B	0.06B	11.39B	0.05B	0.04B	0.03B	0.06B	39.39B	38.18B	15.44B	0.03B	0.08B	0.05B	0.13B	0.07B	0.10B	0.17B	0.06B
Cash from Operations	-0.01B	-0.01B	-0.02B	0.03B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	0.04B	-0.04B	-0.04B	-0.05B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles	0.00B	0.00B	0.00B	0.00B				0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.01B	0.00B	-0.01B			0.00B
Amortization of Deferred Charges	0.00B	0.00B
Depreciation & Amortization (CF)	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Change in Working Capital
Change in Receivables															0.00B	0.01B	0.00B	0.01B	0.01B
Change in Inventory															0.00B	0.01B	0.01B	0.00B	-0.00B
Change in Accured Expenses	0.00B	0.00B	-0.00B	-0.01B	0.00B	-0.00B	0.00B	-0.01B	0.00B	0.00B	0.00B	-0.01B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B
Other Working Capital Changes	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B		-0.00B	-0.00B			-0.00B	-0.00B	0.00B	0.01B	0.00B	-0.00B	-0.00B
Investing Activities
Capital Expenditures	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	-0.01B
Change in Acquisitions & Divestments									0.02B	0.04B	0.06B	0.06B	0.06B	0.07B	0.06B	0.07B	0.06B	0.08B	0.09B
Cash from Investing Activities	-0.00B	-0.00B	-0.04B	0.04B	-0.00B	-0.00B	-0.00B	-0.00B	-0.11B	0.04B	-0.05B	0.03B	-0.01B	-0.01B	0.02B	-0.10B	0.03B	0.05B	-0.04B
Financing Activities
Other financing activities														0.00B	0.00B			0.00B
Cash from Financing Activities	-0.00B	0.00B	0.00B	0.05B	-0.00B	-0.00B	-0.00B	0.19B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.07B	0.00B	0.00B	0.10B
Additional items
Change in Cash	-0.01B	-0.01B	-0.06B	0.12B	-0.01B	-0.01B	-0.01B	0.17B	-0.12B	0.03B	-0.06B	0.01B	-0.01B	-0.02B	0.00B	0.01B	-0.01B	0.01B	0.01B
Beginning Cash Balance	0.39B	0.37B	0.36B	-0.06B	0.24B	0.23B	0.21B	0.04B	0.21B	0.09B	0.12B	0.06B	0.07B	0.06B	0.04B	0.04B	0.05B	0.04B	0.05B
Free Cash Flow	-0.01B	-0.01B	-0.02B	0.03B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	0.04B	-0.04B	-0.05B	-0.04B
Net Cash Flow	-0.01B	-0.01B	-0.06B	0.12B	-0.01B	-0.01B	-0.01B	0.17B	-0.12B	0.03B	-0.06B	0.01B	-0.01B	-0.02B	0.00B	0.01B	-0.01B	0.01B	0.01B

Research Tools

ARS Pharmaceuticals Cash Flow Statement (2021-2025) | SPRY

Create an account

Sign In

Reset Password

Get Pro for 60% off